Ads
related to: lung cancer- Safety & Efficacy Data
Access Clinical Data From A Study
To Learn About The Indication.
- Approval For IMFINZI
Learn About The Indication &
View Data From The POSEIDON Study.
- New POSEIDON Data
View Site For New Data Info &
To Learn About The Indication.
- The POSEIDON Study
Explore Efficacy & Safety Data From
The Trial For The Approval.
- IMFINZI Dosing Regimen
See If The POSEIDON Regimen
Is An Option For Your Patients.
- Request A Representative
Have Questions About IMFINZI? Visit
Site To Speak With A Local Rep.
- Safety & Efficacy Data
Search results
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 2 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...
BREATHE. EASY. Mobile Lung CT Coach To Host "Wipe Out Lung Cancer" At Chattanooga Red Wolves June 5
The Chattanoogan· 5 days agoCHI Memorial’s mobile lung CT coach will host a "Wipe Out Lung Cancer" event at the Chattanooga Red...
South Coast Plaza installation offers 'Music of Hope' to honor cancer survivors
Los Angeles Times· 17 hours agoMichelle Vacca remembers calling into KROQ radio station during the 1980s and winning Beastie Boys...
Ronnie Wood admits 'I shouldn't be here' after double cancer diagnosis
Daily Express· 4 days agoRonnie Wood believed he was handed a death sentence after being diagnosed with cancer. The Rolling...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 1 day agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...
Newswise Expert | Sally York, UT Southwestern Medical Center
Newswise· 15 hours agoDr. Sally York is a medical oncologist and associate professor who treats patients with lung cancer and pleural mesothelioma at the Vanderbilt-Ingram Cancer ...
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...
Benzinga via Yahoo Finance· 5 days agoThursday, Summit Therapeutics Inc (NASDAQ:SMMT) announced that Phase 3 HARMONi-2, or AK112-303, met...
Arrivent Biopharma enters into cancer drug development collaboration valued at up to $615M -...
The Business Journals· 25 minutes agoArriVent Biopharma has made a deal with a Chinese firm on a drug development collaboration potentially valued at more than $600 million. ArriVent, based in Newtown Square, will team with Jiangsu ...
'I've battled skin cancer for 15 years after using sunbeds as a teenager'
Yahoo Life UK· 3 hours agoWhile there is no way of knowing what caused her skin cancer, Madden believes her sunbed usage...